Matches in Wikidata for { <http://www.wikidata.org/entity/Q100396146> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q100396146 description "article scientifique publié en 2020" @default.
- Q100396146 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q100396146 description "scientific article published on 05 June 2020" @default.
- Q100396146 description "wetenschappelijk artikel" @default.
- Q100396146 description "наукова стаття, опублікована 5 червня 2020" @default.
- Q100396146 name "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 name "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 type Item @default.
- Q100396146 label "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 label "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 prefLabel "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 prefLabel "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 P1433 Q100396146-A108046C-92AB-4379-A8F0-EB68C73E72E6 @default.
- Q100396146 P1476 Q100396146-9756C415-CAB4-4C0E-83B6-71D7319F508C @default.
- Q100396146 P2093 Q100396146-2FABA13B-8EAC-4493-82EB-D08C6D89EE50 @default.
- Q100396146 P2093 Q100396146-706766E5-10DB-4515-BF22-4BDECE496891 @default.
- Q100396146 P304 Q100396146-C5EE9958-145F-4433-A4F4-F1971B0B54E4 @default.
- Q100396146 P31 Q100396146-23A64E95-D7F0-42DE-A12C-65D693E3FD8F @default.
- Q100396146 P356 Q100396146-51CE4CDA-C01C-43A1-8C85-E5E68F71CFD8 @default.
- Q100396146 P433 Q100396146-5ECCE551-5F70-41CA-A704-CD448088DBBA @default.
- Q100396146 P478 Q100396146-BDA8663E-7DCA-494E-BC57-51F11F3CB8FD @default.
- Q100396146 P50 Q100396146-3697B1E2-33FB-4A3D-8C8A-8C9126D3100A @default.
- Q100396146 P577 Q100396146-2950CBDE-2919-4461-9FFB-E7FBA35E35C3 @default.
- Q100396146 P698 Q100396146-382AE2B6-00C7-4542-A42A-7A84ACE0080D @default.
- Q100396146 P921 Q100396146-44472AEE-4ACC-4673-9982-304021535B5D @default.
- Q100396146 P921 Q100396146-5D2C6077-F85B-451B-9631-959D4582A52F @default.
- Q100396146 P932 Q100396146-0AA88662-9C8D-47F6-8DAA-60C45632CA44 @default.
- Q100396146 P356 000508740 @default.
- Q100396146 P698 32999889 @default.
- Q100396146 P1433 Q27727384 @default.
- Q100396146 P1476 "Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes?" @default.
- Q100396146 P2093 "Abdullah Abdullah" @default.
- Q100396146 P2093 "Raja Atreya" @default.
- Q100396146 P304 "338-342" @default.
- Q100396146 P31 Q13442814 @default.
- Q100396146 P356 "10.1159/000508740" @default.
- Q100396146 P433 "4" @default.
- Q100396146 P478 "36" @default.
- Q100396146 P50 Q1750078 @default.
- Q100396146 P577 "2020-06-05T00:00:00Z" @default.
- Q100396146 P698 "32999889" @default.
- Q100396146 P921 Q1477 @default.
- Q100396146 P921 Q84263196 @default.
- Q100396146 P932 "7316657" @default.